Abstract:Background: Paclitaxel is a natural anticancer drug, which has demonstrated significant activity in clinical trials. However, it has been limited due to poor aqueous solubility. Chitosan can be modified into graft copolymer, which changed into nanoparticles in aqueous solution, and employed as controlled release carriers for drugs. Objective: To study the characterization, in addition, to evaluate in vitro drug release ability of paclitaxel nanoparticles. Design, time and setting: A repeated measurement design was conducted at the Laboratory of North China Coal Medical University from January 2008 to July 2008. Materials: The average molecular weight of 2.0 × 10 5 chitosan with 92% deacetylation degree was produced by Golden-shell Biochemical Co., Ltd. Paclitaxel (lot number: 082329802) was provided by National Institute for the Control of Pharmaceutical and Biological Products. Methods: The potassium diperiodaton-ickelate served as initiator, chitosan-graft-vinyl acetate copolymers were synthesized by free radical graft copolymerization, which could be directly transformed into nanoparticles with hydrophobic core and hydrophilic surface in the water medium. Paclitaxel nanopartioles were prepared via mixture 0.5-5.0 mg paclitaxel with nanoparticles by ultrasonic irradiation technology. Main outcome measures: Particles size, polydispersity index zeta potential was detected by laser particle size analyzer. The morphology of chitosan nanoparticles and paclitaxel nanoparticles was observed by transmission electron microscope. In addition, encapsulation capability, loading content and in vitro drug release of the paclitaxel nanoparticles was analyzed by high-performance liquid chromatography. Results: The mean diameters of chitosan nanoparticles and paclitaxel nanoparticles were 196.2 nm and 320.8 nm, respectively. The nanoparticles possessed a uniform particles size distribution and an obvious positive charge surface, but the Zeta potential had no significant difference (F=0.818, F=3.38, all P > 0.05). The dose of paclitaxel could affect the encapsulation rate, which could up to 93.6% when added the quantity of paclitaxel was 2% of anoparticles. The results of simulate drug release showed that drug release was reach 48.3% in 24 hours at the burst release phase, which up to 75.9% at 175 hours longer in the slower release phase. The encapsulation rate of drug-loaded nanoparticles was stable. Conclusion: The preparation method is reliable and simple. The nanoparticles possessed good physical performance and sustained release character in vitro.

Preparation,in vitro and in vivo evaluation of actively lung targetable microspheres for paclitaxel delivery

Preparation and characterization of paclitaxel loaded poly(lactic-co-glycolic acid) microspheres

The Anti-Tumor Effects of Lung Cancer-Targeting Long-Circulating Paclitaxel-Containing Liposomes

Preparation and Characterization of Poly(lactic Acid)–poly(ethylene Glycol)–poly(lactic Acid) (PLA–PEG–PLA) Microspheres for Controlled Release of Paclitaxel

Preparation of injectable paclitaxel sustained release microspheres by spray drying for inhibition of glioma in vitro

Preparation and Characterization of PEGylated Paclitaxel Liposomes

Preparation and in Vitro Evaluation of Paclitaxel-Loaded Poly(lactide-co-glycolide) Nanoparticles

Preparation and Targeted Release Evaluation Studies on Micro-Encapsulation of Paclitaxel

In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.

Preparation and in vitro evaluation of paclitaxel-loaded mixed micelles

Release of paclitaxel from polylactide-co-glycolide (PLGA) microparticles and discs under irradiation

Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation in Vivo

Preparation, characterization and drug release property of paclitaxel nanoparticles

Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance

Preparation and in vitro studies of polysaccharide modified compound lipo-somes loaded with paclitaxel and doxorubicin

Controlled drug release capability of paclitaxel-loaded poly(butylcyanoacrylate)-pluronic P123/F68 polymeric micells

Study on Preparation of Paclitaxel-Loaded PEG-PLGA Nanoparticles and in Vitro Experiment

Preparation of paclitaxel loaded PLGA microspheres and its efficacy in Hep-2 laryngeal squamous cell carcinoma-bearing nude mice

[Preparation and Drug Release Property of Paclitaxel Nanoparticles].

Preparation and optimization of poly (lactic-co-glycolic acid) rod-shaped particles in nano size range for paclitaxel delivery.

Characterization and biological evaluation of paclitaxel-loaded poly(L-lactic acid) microparticles prepared by supercritical CO2.